ArticleDiagnostics (Basel, Switzerland)2023

Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers-Early Experiences from Romania and Literature Review.

Camil Ciprian Mireștean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.